Dr. Hope S. Rugo on the SOPHIA Trial in HER2+ Breast Cancer

June 12, 2019
Hope S. Rugo, MD

Cancer Network spoke with Hope S. Rugo, MD, of the University of California, San Francisco, about the results of the phase III SOPHIA trial in HER2-positive breast cancer.

Cancer Network spoke with Hope S. Rugo, MD, of the University of California, San Francisco, about the results of the phase III SOPHIA trial in HER2-positive breast cancer.

Related Content:

ASCO | Conference